Rani Therapeutics' CEO Named PharmaVOICE 100 Honoree
Prolific inventor, serial entrepreneur and creator of the RaniPill™ capsule recognized for unbridled curiosity and passion for solving difficult problems
SAN JOSE, Calif., Aug. 8, 2018 /PRNewswire/ -- Rani Therapeutics, a pioneer in oral biologics, today announced that Chairman and CEO Mir Imran was named to the 2018 PharmaVOICE 100 list, recognizing the most inspiring people in life sciences. Imran has spent nearly 40 years creating and commercializing breakthrough medical innovations. His most recent invention, the RaniPill™ capsule, has the potential to disrupt the pharmaceutical industry by converting injectable medications into pills.
Imran invented a swallowable capsule that delivers biologics without exposing medication to digestive enzymes in the intestinal tract. Once the RaniPill capsule is ingested, it stays protected until it enters the small intestine where it injects medication into the intestinal wall. Covered by more than 50 patents, the RaniPill capsule is suitable for many of the injectable drugs used by patients with rheumatoid arthritis, psoriasis, Crohn's disease, diabetes, osteoporosis, multiple sclerosis, hemophilia, among other diseases and conditions.
"My passion and life's work has been to understand and solve major unmet clinical needs, with the hope that new innovations can positively impact the lives of millions of patients," said Mir Imran, Chairman and CEO of Rani Therapeutics. "Bringing new innovations to market for the benefit of patients keeps me motivated every day and my goal is to continue to push boundaries and solve problems for the rest of my life."
The PharmaVOICE 100 is the only awards program to recognize leaders across a broad cross section of the global life-sciences industry. These leaders are a driving force in the life-sciences industry, who provide inspiration to their peers, colleagues, and companies through their innovative and motivational approaches to addressing the industry's myriad challenges. Honorees are responsible for developing breakthrough strategies, products, and services, and are known for pioneering new paths and lifting their companies to new heights. The full list of recipients can be found at http://www.pharmavoice.com/article/2018-08-pharmavoice100-category/.
About Rani Therapeutics
Rani Therapeutics has developed a novel approach for the oral delivery of large drug molecules including peptides, proteins and antibodies, which to date can only be delivered through injections. The approach and technology for Rani Therapeutics was developed at InCube Labs, a multi-disciplinary life sciences R&D lab focused on developing breakthrough medical innovations. InCube is led by Mir Imran, a prolific medical inventor, entrepreneur and investor. Mir has founded more than 20 life sciences companies and is an inventor on more than 400 issued and pending patents in the U.S and foreign jurisdictions. For more information, please visit: www.ranitherapeutics.com and www.incubelabs.com.
Media Contact:
Cathy Summers
Consort Partners for Rani Therapeutics
rani-therapeutics@consortpartners.com
View original content:http://www.prnewswire.com/news-releases/rani-therapeutics-ceo-named-pharmavoice-100-honoree-300693776.html
SOURCE Rani Therapeutics